Global Nuclear Medicine & Radio Pharmaceuticals Market 2018 - Industry Research Report

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE
 

Global Nuclear Medicine & Radio Pharmaceuticals Market 2018 - Industry Research Report

 Published Date : Oct-2018   |    Format :PDF |    Number of Pages : 114   |    Publisher : Extense Research

In 2017, the global Nuclear Medicine & Radio Pharmaceuticals market size was  million US$ and is forecast to  million US in 2025, growing at a CAGR of  from 2018. The objectives of this study are to define, segment, and project the size of the Nuclear Medicine & Radio Pharmaceuticals market based on company, product type, application and key regions.

This report studies the global market size of Nuclear Medicine & Radio Pharmaceuticals in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Nuclear Medicine & Radio Pharmaceuticals in these regions.
This research report categorizes the global Nuclear Medicine & Radio Pharmaceuticals market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

The various contributors involved in the value chain of Nuclear Medicine & Radio Pharmaceuticals include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Nuclear Medicine & Radio Pharmaceuticals include
    GE Healthcare
    Philips Healthcare
    Siemens Healthcare
    Toshiba
    Hitachi
    Carestream
    Esaote
    Shimadzu
    TriFoil Imaging
    Biosensors International Group, Ltd

Market Size Split by Type
    Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
    Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
Market Size Split by Application
    Diagnostic Applications: SPECT, PET.
    Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.

Market size split by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Nuclear Medicine & Radio Pharmaceuticals market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
    To understand the structure of Nuclear Medicine & Radio Pharmaceuticals market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Nuclear Medicine & Radio Pharmaceuticals manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Nuclear Medicine & Radio Pharmaceuticals with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Nuclear Medicine & Radio Pharmaceuticals submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Nuclear Medicine & Radio Pharmaceuticals are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Nuclear Medicine & Radio Pharmaceuticals market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Study Coverage
    1.1  Nuclear Medicine & Radio Pharmaceuticals Product
    1.2 Key Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Size Growth Rate by Type
        1.4.2 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
        1.4.3 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
    1.5 Market by Application
        1.5.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Size Growth Rate by Application
        1.5.2 Diagnostic Applications: SPECT, PET.
        1.5.3 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Size
        2.1.1 Global Nuclear Medicine & Radio Pharmaceuticals Revenue 2016-2025
        2.1.2 Global Nuclear Medicine & Radio Pharmaceuticals Sales 2016-2025
    2.2 Nuclear Medicine & Radio Pharmaceuticals Growth Rate by Regions
        2.2.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales by Regions
        2.2.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Nuclear Medicine & Radio Pharmaceuticals Sales by Manufacturers
        3.1.1 Nuclear Medicine & Radio Pharmaceuticals Sales by Manufacturers
        3.1.2 Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Manufacturers
        3.1.3 Global Nuclear Medicine & Radio Pharmaceuticals Market Concentration Ratio (CR5 and HHI)
    3.2 Nuclear Medicine & Radio Pharmaceuticals Revenue by Manufacturers
        3.2.1 Nuclear Medicine & Radio Pharmaceuticals Revenue by Manufacturers (2016-2018)
        3.2.2 Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Manufacturers (2016-2018)
    3.3 Nuclear Medicine & Radio Pharmaceuticals Price by Manufacturers
    3.4 Nuclear Medicine & Radio Pharmaceuticals Manufacturing Base Distribution, Product Types
        3.4.1 Nuclear Medicine & Radio Pharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Nuclear Medicine & Radio Pharmaceuticals Product Category
        3.4.3 Date of International Manufacturers Enter into Nuclear Medicine & Radio Pharmaceuticals  Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
    4.1 Global Nuclear Medicine & Radio Pharmaceuticals Sales by Type
    4.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue by Type
    4.3 Nuclear Medicine & Radio Pharmaceuticals Price by Type

5 Breakdown Data by Application
    5.1 Overview
    5.2 Global Nuclear Medicine & Radio Pharmaceuticals Breakdown Data by Application

6 North America
    6.1 North America Nuclear Medicine & Radio Pharmaceuticals by Countries
        6.1.1 North America Nuclear Medicine & Radio Pharmaceuticals Sales by Countries
        6.1.2 North America Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Nuclear Medicine & Radio Pharmaceuticals by Type
    6.3 North America Nuclear Medicine & Radio Pharmaceuticals by Application
    6.4 North America Nuclear Medicine & Radio Pharmaceuticals by Company

7 Europe
    7.1 Europe Nuclear Medicine & Radio Pharmaceuticals by Countries
        7.1.1 Europe Nuclear Medicine & Radio Pharmaceuticals Sales by Countries
        7.1.2 Europe Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Nuclear Medicine & Radio Pharmaceuticals by Type
    7.3 Europe Nuclear Medicine & Radio Pharmaceuticals by Application
    7.4 Europe Nuclear Medicine & Radio Pharmaceuticals by Company

8 Asia Pacific
    8.1 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals by Countries
        8.1.1 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Sales by Countries
        8.1.2 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals by Type
    8.3 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals by Application
    8.4 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals by Company

9 Central & South America
    9.1 Central & South America Nuclear Medicine & Radio Pharmaceuticals by Countries
        9.1.1 Central & South America Nuclear Medicine & Radio Pharmaceuticals Sales by Countries
        9.1.2 Central & South America Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Nuclear Medicine & Radio Pharmaceuticals by Type
    9.3 Central & South America Nuclear Medicine & Radio Pharmaceuticals by Application
    9.4 Central & South America Nuclear Medicine & Radio Pharmaceuticals by Company

10 Middle East and Africa
    10.1 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals by Countries
        10.1.1 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales by Countries
        10.1.2 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals by Type
    10.3 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals by Application
    10.4 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals by Company

11 Company Profiles
    11.1 GE Healthcare
        11.1.1 GE Healthcare Company Details
        11.1.2 Company Description
        11.1.3 Sales, Revenue and Gross Margin of Nuclear Medicine & Radio Pharmaceuticals
        11.1.4 Nuclear Medicine & Radio Pharmaceuticals Product Description
        11.1.5 Recent Development
    11.2 Philips Healthcare
        11.2.1 Philips Healthcare Company Details
        11.2.2 Company Description
        11.2.3 Sales, Revenue and Gross Margin of Nuclear Medicine & Radio Pharmaceuticals
        11.2.4 Nuclear Medicine & Radio Pharmaceuticals Product Description
        11.2.5 Recent Development
    11.3 Siemens Healthcare
        11.3.1 Siemens Healthcare Company Details
        11.3.2 Company Description
        11.3.3 Sales, Revenue and Gross Margin of Nuclear Medicine & Radio Pharmaceuticals
        11.3.4 Nuclear Medicine & Radio Pharmaceuticals Product Description
        11.3.5 Recent Development
    11.4 Toshiba
        11.4.1 Toshiba Company Details
        11.4.2 Company Description
        11.4.3 Sales, Revenue and Gross Margin of Nuclear Medicine & Radio Pharmaceuticals
        11.4.4 Nuclear Medicine & Radio Pharmaceuticals Product Description
        11.4.5 Recent Development
    11.5 Hitachi
        11.5.1 Hitachi Company Details
        11.5.2 Company Description
        11.5.3 Sales, Revenue and Gross Margin of Nuclear Medicine & Radio Pharmaceuticals
        11.5.4 Nuclear Medicine & Radio Pharmaceuticals Product Description
        11.5.5 Recent Development
    11.6 Carestream
        11.6.1 Carestream Company Details
        11.6.2 Company Description
        11.6.3 Sales, Revenue and Gross Margin of Nuclear Medicine & Radio Pharmaceuticals
        11.6.4 Nuclear Medicine & Radio Pharmaceuticals Product Description
        11.6.5 Recent Development
    11.7 Esaote
        11.7.1 Esaote Company Details
        11.7.2 Company Description
        11.7.3 Sales, Revenue and Gross Margin of Nuclear Medicine & Radio Pharmaceuticals
        11.7.4 Nuclear Medicine & Radio Pharmaceuticals Product Description
        11.7.5 Recent Development
    11.8 Shimadzu
        11.8.1 Shimadzu Company Details
        11.8.2 Company Description
        11.8.3 Sales, Revenue and Gross Margin of Nuclear Medicine & Radio Pharmaceuticals
        11.8.4 Nuclear Medicine & Radio Pharmaceuticals Product Description
        11.8.5 Recent Development
    11.9 TriFoil Imaging
        11.9.1 TriFoil Imaging Company Details
        11.9.2 Company Description
        11.9.3 Sales, Revenue and Gross Margin of Nuclear Medicine & Radio Pharmaceuticals
        11.9.4 Nuclear Medicine & Radio Pharmaceuticals Product Description
        11.9.5 Recent Development
    11.10 Biosensors International Group, Ltd
        11.10.1 Biosensors International Group, Ltd Company Details
        11.10.2 Company Description
        11.10.3 Sales, Revenue and Gross Margin of Nuclear Medicine & Radio Pharmaceuticals
        11.10.4 Nuclear Medicine & Radio Pharmaceuticals Product Description
        11.10.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    12.1 Market Opportunities and Drivers
    12.2 Market Challenges
    12.3 Market Risks/Restraints
    12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
    13.1 Value Chain Analysis
        13.1.1 Typical Suppliers of Key Nuclear Medicine & Radio Pharmaceuticals Raw Material
        13.1.2 Nuclear Medicine & Radio Pharmaceuticals Customers
    13.2 Sales Channels Analysis
        13.2.1 Sales Channels Analysis
        13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Author Details
    15.3 Disclaimer



List of Tables and Figures

    Figure Picture of Nuclear Medicine & Radio Pharmaceuticals
    Figure Global Nuclear Medicine & Radio Pharmaceuticals Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
    Figure Global Nuclear Medicine & Radio Pharmaceuticals Production Market Share by Types (Product Category) in 2017
    Figure Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals Product Picture
    Table Major Manufacturers of Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
    Figure Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes Product Picture
    Table Major Manufacturers of Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
    Table Global Nuclear Medicine & Radio Pharmaceuticals Market Size Growth Rate by Application 2018-2025 (K Units)
    Figure Diagnostic Applications: SPECT, PET.
    Figure Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.
    Figure Nuclear Medicine & Radio Pharmaceuticals Report Years Considered
    Figure Global Nuclear Medicine & Radio Pharmaceuticals Market Size 2016-2025 (Million US$)
    Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales 2016-2025 (K Units)
    Table Global Nuclear Medicine & Radio Pharmaceuticals Market Size by Regions 2016-2025 (K Units) & (Million US$)
    Table Global Nuclear Medicine & Radio Pharmaceuticals Sales by Regions 2016-2025 (K Units)
    Table Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Regions 2016-2025
    Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Regions 2016-2025
    Figure 2017 Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Regions
    Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue by Regions 2016-2025 (Million US$)
    Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Regions 2016-2025
    Figure Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Regions 2016-2025
    Figure 2017 Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Regions
    Table Global Nuclear Medicine & Radio Pharmaceuticals Sales by Manufacturers (2016-2018) (K Units)
    Table Global Nuclear Medicine & Radio Pharmaceuticals Sales Share by Manufacturers (2016-2018)
    Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales Share by Manufacturers in 2017
    Table Nuclear Medicine & Radio Pharmaceuticals Revenue by Manufacturers (2016-2018) (Million US$)
    Table Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Manufacturers (2016-2018)
    Figure Nuclear Medicine & Radio Pharmaceuticals Value Share by Manufacturers in 2017
    Table Global Nuclear Medicine & Radio Pharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Manufacturers Nuclear Medicine & Radio Pharmaceuticals Price (2016-2018) (USD/Unit)
    Table Nuclear Medicine & Radio Pharmaceuticals Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Nuclear Medicine & Radio Pharmaceuticals Product Category
    Table Date of International Manufacturers Enter into Nuclear Medicine & Radio Pharmaceuticals Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Nuclear Medicine & Radio Pharmaceuticals Sales by Type (2016-2025) (K Units)
    Table Global Nuclear Medicine & Radio Pharmaceuticals Sales Share by Type (2016-2025)
    Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Type (2016-2025)
    Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Type in 2017
    Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue by Type (2016-2025) (Million US$)
    Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Type (2016-2025)
    Figure Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Type (2016-2025)
    Figure Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Type in 2017
    Table Nuclear Medicine & Radio Pharmaceuticals Price by Type 2013-2018 (USD/Unit)
    Table Global Nuclear Medicine & Radio Pharmaceuticals Sales by Application (2016-2025) (K Units)
    Table Global Nuclear Medicine & Radio Pharmaceuticals Sales Share by Application (2016-2025)
    Figure Global Sales Nuclear Medicine & Radio Pharmaceuticals Market Share by Application (2016-2025)
    Figure Global Sales Nuclear Medicine & Radio Pharmaceuticals Market Share by Application (2016-2025)
    Figure North America Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate 2016-2025 (K Units)
    Figure North America Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate 2016-2025 (Million US$)
    Table North America Nuclear Medicine & Radio Pharmaceuticals Sales by Countries (2016-2025) (K Units)
    Table North America Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Countries (2016-2025)
    Figure 2017 North America Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Countries
    Table North America Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries (2016-2025) (Million US$)
    Table North America Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries (2016-2025)
    Figure 2017 North America Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries
    Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure United States Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Canada Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Canada Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Mexico Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Mexico Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Table North America Nuclear Medicine & Radio Pharmaceuticals Sales by Type (2016-2025) (K Units)
    Table North America Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Type (2016-2025)
    Figure 2017 North America Nuclear Medicine & Radio Pharmaceuticals Market Share by Type
    Table North America Nuclear Medicine & Radio Pharmaceuticals Sales by Application (2016-2025) (K Units)
    Table North America Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Application (2016-2025)
    Figure 2017 North America Nuclear Medicine & Radio Pharmaceuticals Market Share by Application
    Table North America Nuclear Medicine & Radio Pharmaceuticals Sales by Company (2016-2018) (K Units)
    Table North America Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Company (2016-2018)
    Figure North America Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Company in 2017
    Figure Europe Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate 2016-2025 (K Units)
    Figure Europe Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate 2016-2025 (Million US$)
    Table Europe Nuclear Medicine & Radio Pharmaceuticals Sales by Countries (2016-2025) (K Units)
    Table Europe Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Countries (2016-2025)
    Figure 2017 Europe Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Countries
    Table Europe Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries (2016-2025) (Million US$)
    Table Europe Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries (2016-2025)
    Figure 2017 Europe Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries
    Figure Germany Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Germany Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2016-2025) (K Units)
    Figure France Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure France Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2016-2025) (K Units)
    Figure UK Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure UK Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Italy Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Italy Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Russia Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Russia Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Table Europe Nuclear Medicine & Radio Pharmaceuticals Sales by Type (2016-2025) (K Units)
    Table Europe Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Type (2016-2025)
    Figure 2017 Europe Nuclear Medicine & Radio Pharmaceuticals Market Share by Type
    Table Europe Nuclear Medicine & Radio Pharmaceuticals Sales by Application (2016-2025) (K Units)
    Table Europe Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Application (2016-2025)
    Figure 2017 Europe Nuclear Medicine & Radio Pharmaceuticals Market Share by Application
    Table Europe Nuclear Medicine & Radio Pharmaceuticals Sales by Company (2016-2018) (K Units)
    Table Europe Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Company (2016-2018)
    Figure Europe Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Company in 2017
    Figure Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate 2016-2025 (K Units)
    Figure Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate 2016-2025 (Million US$)
    Table Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Sales by Countries (2016-2025) (K Units)
    Table Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Countries
    Table Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries (2016-2025) (Million US$)
    Table Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries
    Figure China Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure China Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Japan Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Japan Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Korea Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Korea Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure India Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure India Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Australia Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Australia Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Indonesia Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Indonesia Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Malaysia Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Malaysia Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Philippines Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Philippines Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Thailand Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Thailand Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Vietnam Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Vietnam Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Singapore Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Singapore Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Table Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Sales by Type (2016-2025) (K Units)
    Table Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Type (2016-2025)
    Figure 2017 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Share by Type
    Table Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Sales by Application (2016-2025) (K Units)
    Table Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Application (2016-2025)
    Figure 2017 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Share by Application
    Table Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Sales by Company (2016-2018) (K Units)
    Table Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Company (2016-2018)
    Figure Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Company in 2017
    Figure Central & South America Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate 2016-2025 (K Units)
    Figure Central & South America Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate 2016-2025 (Million US$)
    Table Central & South America Nuclear Medicine & Radio Pharmaceuticals Sales by Countries (2016-2025) (K Units)
    Table Central & South America Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Countries
    Table Central & South America Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries (2016-2025) (Million US$)
    Table Central & South America Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries
    Figure Brazil Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Brazil Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Argentina Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Argentina Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Table Central & South America Nuclear Medicine & Radio Pharmaceuticals Sales by Type (2016-2025) (K Units)
    Table Central & South America Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Type (2016-2025)
    Figure 2017 Central & South America Nuclear Medicine & Radio Pharmaceuticals Market Share by Type
    Table Central & South America Nuclear Medicine & Radio Pharmaceuticals Sales by Application (2016-2025) (K Units)
    Table Central & South America Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Application (2016-2025)
    Figure 2017 Central & South America Nuclear Medicine & Radio Pharmaceuticals Market Share by Application
    Table Central & South America Nuclear Medicine & Radio Pharmaceuticals Sales by Company (2016-2018) (K Units)
    Table Central & South America Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Company (2016-2018)
    Figure Central & South America Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Company in 2017
    Figure Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate 2016-2025 (K Units)
    Figure Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate 2016-2025 (Million US$)
    Table Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales by Countries (2016-2025) (K Units)
    Table Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Countries
    Table Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Revenue by Countries (2016-2025) (Million US$)
    Table Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Countries
    Figure GCC Countries Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure GCC Countries Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Turkey Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Turkey Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Egypt Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Egypt Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure South Africa Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure South Africa Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Table Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales by Type (2016-2025) (K Units)
    Table Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Type (2016-2025)
    Figure 2017 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Market Share by Type
    Table Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales by Application (2016-2025) (K Units)
    Table Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Application (2016-2025)
    Figure 2017 Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Market Share by Application
    Table Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales by Company (2016-2018) (K Units)
    Table Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Company (2016-2018)
    Figure Middle East and Africa Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Company in 2017
    Table GE Healthcare Company Details
    Table GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table GE Healthcare Recent Development
    Table Philips Healthcare Company Details
    Table Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Philips Healthcare Recent Development
    Table Siemens Healthcare Company Details
    Table Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Siemens Healthcare Recent Development
    Table Toshiba Company Details
    Table Toshiba Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Toshiba Recent Development
    Table Hitachi Company Details
    Table Hitachi Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Hitachi Recent Development
    Table Carestream Company Details
    Table Carestream Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Carestream Recent Development
    Table Esaote Company Details
    Table Esaote Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Esaote Recent Development
    Table Shimadzu Company Details
    Table Shimadzu Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Shimadzu Recent Development
    Table TriFoil Imaging Company Details
    Table TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table TriFoil Imaging Recent Development
    Table Biosensors International Group, Ltd Company Details
    Table Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Biosensors International Group, Ltd Recent Development
    Figure GDP by Regions / Largest Economies Pie Chart in 2016
    Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
    Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
    Figure Saving Rate Total, % of GDP, 2015
    Table Nuclear Medicine & Radio Pharmaceuticals Value Chain
    Table Typical Suppliers of Key Nuclear Medicine & Radio Pharmaceuticals Raw Material
    Table Nuclear Medicine & Radio Pharmaceuticals Customers List
    Table Nuclear Medicine & Radio Pharmaceuticals Sales Channels
    Table Nuclear Medicine & Radio Pharmaceuticals Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

 Select a Format



 Buy Now

24/7 Customer Support

Have questions?

Direct
+1-386-310-3803
Toll Free
+1-855-465-4651
sales@extentresearch.com